CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis

Cancer Science

Volumn 101, Issue 3, 2010, Pages 673-678

  Ishimoto, Takatsugu ^a,b   Oshima, Hiroko ^d   Oshima, Masanobu ^d   Kai, Kazuharu ^a   Torii, Ryota ^e   Masuko, Takashi ^e   Baba, Hideo ^c   Saya, Hideyuki ^a   Nagano, Osamu ^a  

^a KEIO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; PROSTAGLANDIN E2; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CD44+ STEM CELL LIKE SLOW CYCLING CELL; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GASTRIC TUMORIGENESIS; GENE ACTIVATION; GENE FUNCTION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR CELL;

ANIMALS; ANTIGENS, CD44; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICE, TRANSGENIC; RATS; RATS, INBRED F344; STOMACH NEOPLASMS; WNT1 PROTEIN;

EID: 77949593175     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01430.x     Document Type: Article

References (26)

1. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev 2003, 4:33-45.
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61:1303-13.
3. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-68.
4. Takaishi S, Okumura T, Tu S. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-20.
5. Zabierowski SE, Herlyn M. Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 2008, 26:2890-4.
6. Ito K, Bernardi R, Morotti A. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008, 453:1072-8.
7. Holtz M, Forman SJ, Bhatia R. Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment. Cancer Res 2007, 67:1113-20.
8. Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
9. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006, 131:1086-95.
10. Oshima M, Oshima H, Matsunaga A, Taketo MM. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 2005, 65:9147-51.
11. Okamoto I, Morisaki T, Sasaki J. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. J Natl Cancer Inst 1998, 90:307-15.
12. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004, 23:1669-78.
13. Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993, 341:725-6.
14. Mayer B, Jauch KW, Gunthert U. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993, 342:1019-22.
15. Miwa T, Watanabe A, Yamada Y. Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer 1996, 77:25-9.
16. Zou GM. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 2008, 217:598-604.
17. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004, 4:45-60.
18. Odze RD. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 2005, 100:1853-67.
19. Qiao XT, Ziel JW, McKimpson W. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 2007, 133:1989-98.
20. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 2002, 115:2381-8.
21. McDonald SA, Greaves LC, Gutierrez-Gonzalez L. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 2008, 134:500-10.
22. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-50.
23. North TE, Goessling W, Walkley CR. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007, 447:1007-11.
24. Goessling W, North TE, Loewer S. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009, 136:1136-47.
25. Bleuming SA, He XC, Kodach LL. Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Res 2007, 67:8149-55.
26. Wang D, Wang H, Shi Q. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell 2004, 6:285-95.